Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.

Oprah Winfrey says taking a GLP-1 drug such as Ozempic and Wegovy has changed her entire perspective on “thin people.” A Type 2 diabetes medication that can also aid in weight loss ...

Today, GLP-1 drugs, including Wegovy, Mounjaro and Zepbound, have become household names and key tools in the fight against obesity: 1 in 8 American adults say they have used a GLP-1 drug ...

When Rice reached her goal weight, she tried phasing out semaglutide (marketed as Wegovy for weight loss ... which includes products such as Mounjaro. Rice is among users who take compounded ...

This marks Heap’s first-ever entry on the Hot 100. Even though Heap herself has never had a solo hit on the chart, her songs have made waves here before. Jason Derulo sampled “Hide and Seek” ...

Ozempic and Wegovy have been added to Medicare's list of drugs whose prices will be negotiated between drug makers and the government. There's a lot of uncertainty on which direction the Trump ...

It is the largest study ever of the drug category—which includes Novo Nordisk’s GLP-1 treatments Ozempic and Wegovy and Eli Lilly’s dual-action GLP-1/GIP agonists Mounjaro and Zepbound.

The study included people taking different types drugs in this category—semaglutide (Wegovy and Ozempic), and tirzepatide (Mounjaro and Zepbound). While tirzepatide targets two hormones—GLP-1 ...

About 140,400 obese patients in Massachusetts were prescribed medications such as Wegovy and Zepbound in ... 100 pounds in a little over a year on Mounjaro, made by Eli Lilly.

Ozempic, Wegovy, Mounjaro, and Zepbound are all classified as GLP-1 drugs. These medications, which are taken by injection, work by simulating naturally produced hormones that curb appetite and ...

A landmark study involving over 2 million patients shows weight loss drugs like Ozempic, Wegovy, and Mounjaro double the risk of pancreatitis and cause increased incidents of nausea, arthritis, and ...

Weight-loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists include Ozempic, Mounjaro, Wegovy and Zepbound—and they can be prescribed for obesity or type 2 diabetes.